Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma
Osteosarcoma is one of the most prevalent primary bone tumors with a high metastatic and
recurrence rate with poor prognosis. MiRNAs are short and non-coding RNAs that could …
recurrence rate with poor prognosis. MiRNAs are short and non-coding RNAs that could …
[HTML][HTML] HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target
HOX genes occupy a significant role in embryogenesis, hematopoiesis, and oncogenesis.
HOXA5, a member of the A cluster of HOX genes, is essential for establishing the skeleton …
HOXA5, a member of the A cluster of HOX genes, is essential for establishing the skeleton …
Regulation of the epithelial to mesenchymal transition in osteosarcoma
K Hinton, A Kirk, P Paul, S Persad - Biomolecules, 2023 - mdpi.com
The epithelial to mesenchymal transition (EMT) is a cellular process that has been linked to
the promotion of aggressive cellular features in many cancer types. It is characterized by the …
the promotion of aggressive cellular features in many cancer types. It is characterized by the …
The diagnostic and prognostic values of microRNA-196a in cancer
M Xiong, P Wang, B Pan, J Nie, S Wang… - Bioscience …, 2021 - portlandpress.com
Abstract MicroRNA-196a (miR-196a) was previously reported to be up-regulated in cancers,
and it has the diagnostic and prognostic values in cancers. Whereas, the conclusion was still …
and it has the diagnostic and prognostic values in cancers. Whereas, the conclusion was still …
miR-196a upregulation contributes to gefitinib resistance through inhibiting GLTP expression
BJ Liu, FF Li, YX Xie, CY Fan, WJ Liu, JG Qiu… - International Journal of …, 2022 - mdpi.com
Tyrosine kinase inhibitor (TKI) therapy has greatly improved lung cancer survival in patients
with epidermal growth factor receptor (EGFR) mutations. However, the development of TKI …
with epidermal growth factor receptor (EGFR) mutations. However, the development of TKI …
[HTML][HTML] Transcriptome Sequencing reveals the expressed profiles of mRNA and ncRNAs and regulate network via ceRNA mediated molecular mechanism of lung …
L Han, Z Yao, L Xie, D Li, C Wang, Y Yang… - Translational Cancer …, 2021 - ncbi.nlm.nih.gov
Background The most ordinary subtype of lung cancer is lung adenocarcinoma (LuAC),
which is characterized by strong metastatic ability. And LuAC rates in Xuanwei leads to the …
which is characterized by strong metastatic ability. And LuAC rates in Xuanwei leads to the …
Roles of miR-196a and miR-196b in Zebrafish Motor Function
C Yuan, H Xie, X Chen, S Yuan - Biomolecules, 2023 - mdpi.com
Background: The exertion of motor function depends on various tissues, such as bones and
muscles. miR-196 has been widely studied in cancer and other fields, but its effect on bone …
muscles. miR-196 has been widely studied in cancer and other fields, but its effect on bone …
MPP8 promotes proliferation and restrains apoptosis in osteosarcoma by regulating p38αMAPK pathway
T Li, N Li, L Wang, J Li, X Zhang - Technology in Cancer …, 2021 - journals.sagepub.com
Osteosarcoma is the most common primary bone malignancy. We aim to investigate that role
of M-phase phosphoprotein 8 (MPP8) on proliferation and apoptosis in osteosarcoma …
of M-phase phosphoprotein 8 (MPP8) on proliferation and apoptosis in osteosarcoma …
MicroRNAs as potential biomarkers in the differential diagnosis of lipomatous tumors and their mimics
HM Tan, H Cheng, YC Tang, SM Leong… - International Journal of …, 2022 - mdpi.com
Adipocytic tumors are the most common subtype of soft tissue tumors. In current clinical
practice, distinguishing benign lipomas from well-differentiated liposarcomas (WDLPS), as …
practice, distinguishing benign lipomas from well-differentiated liposarcomas (WDLPS), as …
RETRACTED ARTICLE: Research on Correlations of miR-196a Expression with Progression and Prognosis of Cutaneous Squamous Cell Carcinoma
W Zhang, X Yang, J Lv, S An - Clinical, Cosmetic and …, 2022 - Taylor & Francis
Zhang W, Yang X, Lv J, An S. Clin Cosmet Investig Dermatol. 2022; 15: 97–105. We, the
Editors and Publisher of Clinical, Cosmetic and Investigational Dermatology, have retracted …
Editors and Publisher of Clinical, Cosmetic and Investigational Dermatology, have retracted …